We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$949M
AUM Growth
+$10.7M
Cap. Flow
-$13.1M
Cap. Flow %
-1.38%
Top 10 Hldgs %
22.38%
Holding
286
New
5
Increased
81
Reduced
149
Closed
5

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.25%
2 Healthcare 14.37%
3 Financials 12.31%
4 Consumer Staples 12.04%
5 Technology 11.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOR icon
251
Worthington Enterprises
WOR
$2.8B
$259K 0.03%
8,360
JWN
252
DELISTED
Nordstrom
JWN
$248K 0.03%
5,193
-29
-0.6% -$1.32K
CVGW
253
DELISTED
Calavo Growers
CVGW
$247K 0.03%
3,575
XLY icon
254
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.1B
$242K 0.03%
+5,398
New +$242K
IWN icon
255
iShares Russell 2000 Value ETF
IWN
$14.5B
$240K 0.03%
2,020
IWD icon
256
iShares Russell 1000 Value ETF
IWD
$84.3B
$239K 0.03%
2,049
XLV icon
257
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$238K 0.03%
+3,008
New +$229K
BEN icon
258
Franklin Templeton
BEN
$17.6B
$229K 0.02%
5,118
-250
-5% -$10.7K
BIO icon
259
Bio-Rad Laboratories Class A
BIO
$10.4B
$229K 0.02%
1,010
NVS icon
260
Novartis
NVS
$292B
$224K 0.02%
2,993
-414
-12% -$29.3K
IJK icon
261
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$220K 0.02%
4,476
+212
+5% +$10.3K
SPGI icon
262
S&P Global
SPGI
$131B
$214K 0.02%
+1,468
New +$204K
NUVA
263
DELISTED
NuVasive, Inc.
NUVA
$211K 0.02%
2,748
CHTR icon
264
Charter Communications
CHTR
$18.3B
$209K 0.02%
619
IYE icon
265
iShares US Energy ETF
IYE
$1.83B
$209K 0.02%
5,884
AAP icon
266
Advance Auto Parts
AAP
$2.59B
$208K 0.02%
1,781
DYSL
267
DELISTED
Dynasil Corporation of America
DYSL
$174K 0.02%
141,220
+4,960
+4% +$6.41K
LQMT
268
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
$61K 0.01%
213,000
ATNM icon
269
Actinium Pharmaceuticals
ATNM
$31.7M
$28K ﹤0.01%
762
TNDM icon
270
Tandem Diabetes Care
TNDM
$1.49B
$14K ﹤0.01%
1,757
RGLS
271
DELISTED
Regulus Therapeutics
RGLS
$11K ﹤0.01%
96
ADNT icon
272
Adient
ADNT
$1.47B
-3,078
Closed -$224K
HSY icon
273
Hershey
HSY
$36B
-2,017
Closed -$220K
VRDN icon
274
Viridian Therapeutics
VRDN
$2.61B
-2,666
Closed -$498K
YHOO
275
DELISTED
Yahoo Inc
YHOO
-42,975
Closed -$1.99M

Similar funds

Dowling & Yahnke's Q2 2017 Portfolio in Review

As of Q2 2017, Dowling & Yahnke held 286 positions worth $949M, up 1.1% from $939M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 3.5%. Dowling & Yahnke opened 5 new positions and exited 5, leaving the 286-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Dowling & Yahnke's largest Q2 2017 buy was Altaba Inc: 44,542 shares worth $2.43M.
  • Dowling & Yahnke added most to DexCom in Q2 2017, an estimated $355K increase.
  • Dowling & Yahnke's biggest Q2 2017 reduction was Reliance Steel & Aluminium, cutting an estimated $1.96M.
  • Dowling & Yahnke fully exited Yahoo Inc in Q2 2017, selling an estimated $1.99M.
  • Dowling & Yahnke's ten largest holdings make up 22% of its $949M portfolio in Q2 2017.
  • Dowling & Yahnke opened 5 new positions and closed 5 in Q2 2017.
  • Dowling & Yahnke's portfolio value rose 1.1% quarter-over-quarter to $949M.

Based on Dowling & Yahnke's 13F filing for Q2 2017, filed 3 Aug 2017.